Thermal Testicular Contraception Trial Shows High Suppression Rates in Geneva
A one-year clinical observation at HUG involving approximately 30 participants tracking thermal testicular contraception has recorded high sperm suppression rates, though medical experts emphasize that significant safety questions remain.
The trial examined thermal testicular contraception using specialized rings or undergarments designed to elevate testicular temperature by roughly 1.5 degrees Celsius. This modest thermal increase suppresses sperm production by pulling the testicles closer to the body. HUG followed thirty users over twelve months, conducting sperm analyses and monitoring local side effects and user experiences.
Nearly 80 percent of the participants achieved at least one sperm count reaching the contraceptive threshold of one million sperm per milliliter. Most users reported satisfaction with the approach, and only three individuals dropped out of the study. Reported side effects were limited primarily to local skin irritation and minor urinary discomfort.
Unresolved Safety Questions and Long-Term Risks
Despite the high suppression rates, Arsever underscored that there is insufficient evidence to validate the practice. Critical data regarding the return to fertility after stopping use remain lacking. Furthermore, while specialists estimate the risk to be low, the potential link between prolonged thermal elevation of the testes and testicular cancer has not been clearly established.
The investigation into male contraceptive options extends beyond thermal devices. In Lille, a French research team is developing an implantable, hormone-free alternative. This experimental device places two small clips on the vas deferens to divert sperm toward the scrotum. Currently tested in dogs, human safety trials for the device could begin within the next few years. Funding remains a primary hurdle for the French team, requiring tens of millions of euros to navigate regulatory pathways.
Contraceptive Responsibility and Historical Double Standards
Beyond device engineering, researchers emphasize the broader social question of contraceptive responsibility. Arsever noted that individuals with penises can already share contraceptive responsibility by consistently using condoms or engaging with their partners’ methods. She also pointed to historical disparities in how side effects are evaluated across genders, noting that a prior injectable hormonal male contraceptive trial was halted in the 2010s due to adverse effects, even though 80 percent of participants wanted to continue, whereas side effects in female contraceptives, often more severe, have not prevented their commercialization.
Frequently Asked Questions About Thermal Testicular Contraception
How does thermal testicular contraception work?
The method uses specialized rings or tailored underwear to maintain the testicles closer to the body, raising their temperature by approximately 1.5 degrees Celsius to reduce sperm production.
What were the main side effects reported in the Geneva study?
Participants in the HUG trial primarily reported local skin irritations and minor urinary discomfort during the one-year observation period.
What safety concerns do doctors still have about the method?
Medical professionals point to insufficient data regarding the return to fertility after stopping use, alongside a lack of evidence concerning potential links to testicular cancer.
Worth a look